ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

41,238Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 978

$2.83M Total Retail Price of All Prescriptions

Rank: 2 out of 978

1,089 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 1,089 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 1,089 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 27,202 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 1,602 1,122 1 1
SIMVASTATIN 1,402 1,035 2 2
AMLODIPINE BESYLATE 1,270 1,004 3 6
OMEPRAZOLE 1,258 785 4 3
ATORVASTATIN CALCIUM 1,075 764 5 12
LEVOTHYROXINE SODIUM 877 532 6 4
METFORMIN HCL ER 862 500 10 7 48
ATENOLOL 730 584 8 8
FUROSEMIDE 679 527 9 9
ALENDRONATE SODIUM 620 503 10 20
METFORMIN HCL 607 460 11 7
CRESTOR 602 480 12 30
PRAVASTATIN SODIUM 577 395 13 16
HYDROCHLOROTHIAZIDE 556 436 14 5
GABAPENTIN 552 321 15 15
PANTOPRAZOLE SODIUM 548 406 16 39
METOPROLOL TARTRATE 529 419 17 10
CELEBREX 521 312 18 94
JANUVIA 483 284 19 82
CITALOPRAM HBR 460 207 20 14
MECLIZINE HCL 456 340 21 120
GLIMEPIRIDE 445 321 22 63
SERTRALINE HCL 436 165 23 21
ZOLPIDEM TARTRATE 423 213 24 32
TRAMADOL HCL 410 219 25 24
ALLOPURINOL 406 322 26 34
OXYCODONE-ACETAMINOPHEN 401 181 S2 27 25
METOPROLOL SUCCINATE 395 238 28 13
TAMSULOSIN HCL 355 302 29 33
WARFARIN SODIUM 335 254 30 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 331 229 31 36
SINGULAIR 323 192 32 124
LOSARTAN POTASSIUM 319 241 33 22
TERAZOSIN HCL 312 246 34 76
ADVAIR DISKUS 311 212 35 35
TRAZODONE HCL 300 199 36 18
FLUTICASONE PROPIONATE 298 162 37 28
PROAIR HFA 298 157 37 19
PRADAXA 283 274 39 180
DONEPEZIL HCL 271 267 40 26
LIDODERM 259 159 41 65
QUINAPRIL HCL 258 200 42 95
ISOSORBIDE MONONITRATE ER 257 210 43 57
MIRTAZAPINE 255 188 44 31
OXYCODONE HCL-ACETAMINOPHEN 252 115 S2 45 78
ORPHENADRINE CITRATE 250 120 R 10 46 196
CYMBALTA 243 67 47 60
CARVEDILOL 237 179 48 55
MONTELUKAST SODIUM 232 142 49 201
AMITRIPTYLINE HCL 222 61 R 50 59
PRANDIN 220 182 51 209
TRICOR 213 102 52 144
IBUPROFEN 205 67 53 38
PROPRANOLOL HCL 198 74 54 114
ENALAPRIL MALEATE 198 137 54 64
SPIRIVA 190 115 56 37
DIOVAN 186 124 57 43
TOPIRAMATE 184 84 58 160
NEXIUM 184 112 58 77
DIGOXIN 176 158 60 54
CLOPIDOGREL 176 115 60 61
TRIAMTERENE-HCTZ 171 112 62 67
LIPITOR 166 105 63 84
PAROXETINE HCL 166 148 63 52
CALCITRIOL 166 112 63 207
HYDROCODONE-ACETAMINOPHEN 155 93 S3 66 17
FENOFIBRATE 153 90 67 53
ONGLYZA 151 128 68 216
ESCITALOPRAM OXALATE 144 75 69 117
PLAVIX 140 93 70 96
TIZANIDINE HCL 139 53 71 182
ACTOS 138 106 72 89
DILTIAZEM 24HR ER 138 104 72 69
ZETIA 137 80 74 109
FLUOXETINE HCL 137 63 74 42
COMBIVENT 132 63 76 110
FINASTERIDE 130 107 77 72
RISPERIDONE 126 66 78 49
NIASPAN 126 34 78 158
TRADJENTA 122 122 80 253
ACTONEL 122 91 80 219
VERAPAMIL ER 122 93 80 88
VICTOZA 3-PAK 120 29 83 255
KLOR-CON M20 119 105 84 66
PREDNISONE 114 80 85 47
QUETIAPINE FUMARATE 114 65 85 51
SYMBICORT 113 40 87 140
EVISTA 113 61 87 130
LOVASTATIN 112 69 89 29
HYDROXYZINE HCL 111 50 R 90 186
DETROL LA 110 92 91 153
NAPROXEN 107 41 92 73
NAMENDA 106 106 93 45
DIOVAN HCT 104 80 94 154
OXYCONTIN 104 22 S2 94 79
NITROGLYCERIN PATCH 104 97 94 151
OXYCODONE HCL 102 0 S2 97 23
LOSARTAN-HYDROCHLOROTHIAZIDE 98 78 98 122
COLCRYS 97 92 99 215
LEVEMIR FLEXPEN 97 62 99 237
SPIRONOLACTONE 96 85 101 87
AMLODIPINE BESYLATE-BENAZEPRIL 96 70 101 173
CILOSTAZOL 95 95 103 270
RANITIDINE HCL 93 65 104 27
NYSTOP 92 59 105 118
NABUMETONE 92 51 105 151
DEXILANT 91 31 107 104
LANTUS 89 52 108 40
NITROSTAT 87 63 109 239
AZITHROMYCIN 86 56 110 68
POLYETHYLENE GLYCOL 3350 84 65 111 58
THEOPHYLLINE ANHYDROUS 84 70 111 280
INSULIN SYRINGE 83 59 113 80
LYRICA 82 53 114 197
MORPHINE SULFATE ER 80 22 S2 115 71
BUPROPION HCL SR 80 24 115 115
ALBUTEROL SULFATE 79 68 117 132
LACTULOSE 79 56 117 92
BENAZEPRIL HCL 78 63 119 233
BUMETANIDE 74 53 120 190
NITROFURANTOIN 73 65 121 211
OLANZAPINE 71 25 122 75
JANTOVEN 71 62 122 184
CEFADROXIL 71 55 122 289
AMITIZA 70 24 125 250
VENLAFAXINE HCL ER 70 29 125 86
GEMFIBROZIL 69 48 127 97
DILTIAZEM HCL 68 68 128 250
HYDROCORTISONE 67 43 129 255
VYTORIN 65 54 130 300
METHIMAZOLE 64 47 131 302
NYSTATIN 64 47 131 126
PEN NEEDLE 63 37 133 179
CLOTRIMAZOLE 63 33 133 304
SEROQUEL XR 63 55 133 304
BONIVA 61 41 136 308
LEVOFLOXACIN 61 41 136 98
ETODOLAC 61 30 136 161
ABILIFY 60 17 139 106
ROPINIROLE HCL 60 23 139 138
AMOX TR-POTASSIUM CLAVULANATE 60 36 139 169
TORSEMIDE 59 39 142 212
PROCHLORPERAZINE MALEATE 59 18 142 222
VOLTAREN 58 36 144 319
METHYLPREDNISOLONE 57 33 145 262
CYCLOBENZAPRINE HCL 57 21 R 145 62
NIFEDIPINE ER 56 51 147 70
BISOPROLOL-HYDROCHLOROTHIAZIDE 54 52 148 148
LABETALOL HCL 54 48 148 142
DIVALPROEX SODIUM 54 35 148 56
PIOGLITAZONE HCL 53 39 R 151 214
DOXYCYCLINE HYCLATE 51 12 152 146
AZELASTINE HCL 51 28 152 336
NIFEDICAL XL 50 50 154 265
POTASSIUM CHLORIDE 50 49 154 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.